Presentation TCT 2012

Percutaneous Transcatheter Pulmonary Valve Implantation Induces a Reduction of B-Type Natriuretic Peptide at 30 days.

Presenter: Joelle Kefer, Thierry Sluysmans, St?phane Moniotte, Jean-Marie Gapira, Christophe Beauloye, Agnes Pasquet

January 03, 2012

REGISTER for free or LOG IN to view this content

Percutaneous Transcatheter Pulmonary Valve Implantation Induces a Reduction of B-Type Natriuretic Peptide at 30 days.

Structural Heart

Presentation

TCT 2012

Up Next

Presentation TCT 2012

Impact on the need for permanent pacemaker requirement after CoreValve prosthesis implantation with the new Accutrak delivery Catheter System

Presenter: Antonio J. Mu?oz-Garc?a

January 03, 2012

More slides +

Presentation TCT 2012

EVEREST II High Surgical Risk Cohort: Clinical Benefit by MR Grade in High Surgical Risk Patients One Year Following MitraClip Therapy.

Presenter: Paul Grayburn

January 03, 2012

Presentation

Dabigatran Association with Higher Risk of Acute Coronary Events

Presenter: Ken Uchino

January 09, 2012

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.